Not provided
Not provided
Not provided
Not provided
Not provided
No participants have been enrolled to date. The study is currently under consideration for early termination due to recruitment challenges.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Radiofrequency ablation of the medial nerve is the current surgical treatment for back pain originating from the facet joints in the spine. However, this procedure causes denervation of spinal muscles. Peripheral nerve stimulation is another treatment for facet joint pain that may not cause damage to the spinal muscles. This study will compare both treatments in terms pain relief and spine biomechanics.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Peripheral Nerve Stimulation | Experimental | Peripheral nerve stimulation (PNS) is a procedure used to relieve chronic back pain by targeting the nerves responsible for transmitting pain signals from the back to the brain. It is a minimally invasive approach that aims to disrupt the pain signals and provide pain relief. |
|
| Radiofrequency Ablation | Active Comparator | Radiofrequency ablation (RFA) is the current standard of care for facet joint pain. It is a minimally invasive procedure used to relieve chronic back or neck pain caused by issues with the small joints in the spine called facet joints. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Sprint PNS system | Device | Temporary electrical stimulation of the medial nerve with implanted wires and wearable stimulator |
|
| Measure | Description | Time Frame |
|---|---|---|
| Multifidus muscle activity | Muscle contraction quantification via shear wave elastography | pre-treatment |
| Multifidus muscle activity | Muscle contraction quantification via shear wave elastography | within two weeks of treatment completion |
| Multifidus muscle activity | Muscle contraction quantification via shear wave elastography | 12 months after pre-treatment measurement |
| Measure | Description | Time Frame |
|---|---|---|
| Pain Intensity | Visual Analog Scale, scale range 1 - 10, 10 being worse possible pain. | pre-treatment |
| Pain Intensity | Visual Analog Scale, scale range 1 - 10, 10 being worse possible pain. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Daniel H. Cortes, Ph.D. | Penn State University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hershey Medical Center | Hershey | Pennsylvania | 17033 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000078703 | Radiofrequency Ablation |
| ID | Term |
|---|---|
| D000078702 | Radiofrequency Therapy |
| D013812 | Therapeutics |
| D055011 | Ablation Techniques |
| D013514 | Surgical Procedures, Operative |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Radiofrequency Ablation | Procedure | Thermal ablation of the medial nerve |
|
| within two weeks of treatment completion |
| Pain Intensity | Visual Analog Scale, scale range 1 - 10, 10 being worse possible pain. | 12 months after pre-treatment measurement |
| Oswestry Disability Index | Survey evaluating disability level, 0 - 4 No disability 5 - 14 Mild disability 15 - 24 Moderate disability 25 - 34 Severe disability 35 - 50 Completely disabled | pre-treatment |
| Oswestry Disability Index | Survey evaluating disability level, 0 - 4 No disability 5 - 14 Mild disability 15 - 24 Moderate disability 25 - 34 Severe disability 35 - 50 Completely disabled | within two weeks of treatment completion |
| Oswestry Disability Index | Survey evaluating disability level, 0 - 4 No disability 5 - 14 Mild disability 15 - 24 Moderate disability 25 - 34 Severe disability 35 - 50 Completely disabled | 12 months after pre-treatment measurement |
| PROMIS-29 v2.0 | Survey assessing pain intensity using a single 0-10 numeric rating item and seven health domains (physical function, fatigue, pain interference, depressive symptoms, anxiety, ability to participate in social roles and activities, and sleep disturbance) | pre-treatment |
| PROMIS-29 v2.0 | Survey assessing pain intensity using a single 0-10 numeric rating item and seven health domains (physical function, fatigue, pain interference, depressive symptoms, anxiety, ability to participate in social roles and activities, and sleep disturbance) | within two weeks of treatment completion |
| PROMIS-29 v2.0 | Survey assessing pain intensity using a single 0-10 numeric rating item and seven health domains (physical function, fatigue, pain interference, depressive symptoms, anxiety, ability to participate in social roles and activities, and sleep disturbance) | 12 months after pre-treatment measurement |
| isometric back strength | Measurement of peak force generated by the torso in extension in Newtons | pre-treatment |
| Isometric back strength | Measurement of peak force generated by the torso in extension in Newtons | within two weeks of treatment completion |
| isometric back strength | Measurement of peak force generated by the torso in extension in Newtons | 12 months after pre-treatment measurement |
| Functional Reach | distance between the length of an outstretched arm in a maximal forward reach, 10"/25 cm or greater Low risk of falls, 6"/15cm to 10"/25cm Risk of falling is 2x greater than normal, 6"/15cm or less Risk of falling is 4x greater than normal, Unwilling to reach Risk of falling is 8x greater than normal. | pre-treatment |
| Functional Reach | distance between the length of an outstretched arm in a maximal forward reach, 10"/25 cm or greater Low risk of falls, 6"/15cm to 10"/25cm Risk of falling is 2x greater than normal, 6"/15cm or less Risk of falling is 4x greater than normal, Unwilling to reach Risk of falling is 8x greater than normal. | within two weeks of treatment completion |
| Functional Reach | distance between the length of an outstretched arm in a maximal forward reach, 10"/25 cm or greater Low risk of falls, 6"/15cm to 10"/25cm Risk of falling is 2x greater than normal, 6"/15cm or less Risk of falling is 4x greater than normal, Unwilling to reach Risk of falling is 8x greater than normal. | 12 months after pre-treatment measurement |
| Repetitive Trunk Rotation | Time to complete 20 rotations, seconds, longer times are worse performance. | pre-treatment |
| Repetitive Trunk Rotation | Time to complete 20 rotations, seconds, longer times are worse performance. | within two weeks of treatment completion |
| Repetitive Trunk Rotation | Time to complete 20 rotations, seconds, longer times are worse performance. | 12 months after pre-treatment measurement |
| Repeated Chair Stands | Time to perform 5 repeated chair stands, higher times mean worse outcomes. | pre-treatment |
| Repeated Chair Stands | Time to perform 5 repeated chair stands, higher times mean worse outcomes. | within two weeks of treatment completion |
| Repeated Chair Stands | Time to perform 5 repeated chair stands, higher times mean worse outcomes. | 12 months after pre-treatment measurement |
| Pfirmmann grade | Degeneration of lumbar discs at the treated level, grade 1 - 5, 1 is normal and 5 is completely collapsed disc. | pre-treatment |
| Pfirmmann grade | Degeneration of lumbar discs at the treated level, grade 1 - 5, 1 is normal and 5 is completely collapsed disc. | within two weeks of treatment completion |
| Pfirmmann grade | Degeneration of lumbar discs at the treated level, grade 1 - 5, 1 is normal and 5 is completely collapsed disc. | 12 months after pre-treatment measurement |
| t2-relaxation time | T2 relaxation time of the disc at the treated level. Lower values indicate more degeneration. | pre-treatment |
| t2-relaxation time | T2 relaxation time of the disc at the treated level. Lower values indicate more degeneration. | within two weeks of treatment completion |
| t2-relaxation time | T2 relaxation time of the disc at the treated level. Lower values indicate more degeneration. | 12 months after pre-treatment measurement |
| 2-point dixon MRI | Intramuscular fat percentage, higher percentage means worse outcome. | pre-treatment |
| 2-point dixon MRI | Intramuscular fat percentage, higher percentage means worse outcome. | within two weeks of treatment completion |
| 2-point dixon MRI | Intramuscular fat percentage, higher percentage means worse outcome. | 12 months after pre-treatment measurement |